"Parkinson Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Descriptor ID |
D010300
|
| MeSH Number(s) |
C10.228.140.079.862.500 C10.228.662.600.400 C10.574.812
|
| Concept/Terms |
Parkinson Disease- Parkinson Disease
- Idiopathic Parkinson's Disease
- Lewy Body Parkinson Disease
- Lewy Body Parkinson's Disease
- Primary Parkinsonism
- Parkinsonism, Primary
- Parkinson Disease, Idiopathic
- Parkinson's Disease
- Parkinson's Disease, Idiopathic
- Parkinson's Disease, Lewy Body
- Idiopathic Parkinson Disease
- Paralysis Agitans
|
Below are MeSH descriptors whose meaning is more general than "Parkinson Disease".
Below are MeSH descriptors whose meaning is more specific than "Parkinson Disease".
This graph shows the total number of publications written about "Parkinson Disease" by people in this website by year, and whether "Parkinson Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 1 | 3 |
| 2010 | 4 | 0 | 4 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 1 | 3 |
| 2013 | 4 | 1 | 5 |
| 2014 | 4 | 0 | 4 |
| 2015 | 9 | 2 | 11 |
| 2016 | 9 | 2 | 11 |
| 2017 | 121 | 6 | 127 |
| 2018 | 107 | 13 | 120 |
| 2019 | 33 | 4 | 37 |
| 2020 | 17 | 1 | 18 |
| 2021 | 15 | 2 | 17 |
| 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Parkinson Disease" by people in Profiles.
-
Implication of Covid-19 on Neurological Complications with Specific Emphasis on Alzheimer's and Parkinson's Disease. CNS Neurol Disord Drug Targets. 2022; 21(3):235-245.
-
The Impact of COVID-19 on Community-Based Exercise Classes for People With Parkinson Disease. Phys Ther. 2021 11 01; 101(11).
-
Physical Activity and Perceived Health in People With Parkinson Disease During the First Wave of Covid-19 Pandemic: A Cross-sectional Study From Sweden. J Neurol Phys Ther. 2021 10 01; 45(4):266-272.
-
Prolonged Dysphagia After a COVID-19 Infection in a Patient With Parkinson Disease. Am J Phys Med Rehabil. 2021 09 01; 100(9):837-839.
-
Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown. BMC Neurol. 2021 Aug 30; 21(1):332.
-
Effects of the Coronavirus Disease 2019 Pandemic on Motor Symptoms in Parkinson's Disease: An Observational Study. Mov Disord. 2021 11; 36(11):2461-2463.
-
Longitudinal observational study of boxing therapy in Parkinson's disease, including adverse impacts of the COVID-19 lockdown. BMC Neurol. 2021 Aug 24; 21(1):326.
-
Severe Dyskinesia After Administration of SARS-CoV2 mRNA Vaccine in Parkinson's Disease. Mov Disord. 2021 10; 36(10):2219.
-
Covid-19 and Parkinson's disease: an overview. J Neurol. 2021 Dec; 268(12):4415-4421.
-
Genetic Exchange of Lung-Derived Exosome to Brain Causing Neuronal Changes on COVID-19 Infection. Mol Neurobiol. 2021 Oct; 58(10):5356-5368.